International Biotechnology Trust plc
IBT.L · LSE
8/31/2025 | 2/28/2025 | 8/31/2024 | 2/29/2024 | |
|---|---|---|---|---|
| Market Cap | £244 | £249 | £250 | £266 |
| - Cash | £15 | £4 | £10 | £9 |
| + Debt | £30 | £36 | £23 | £28 |
| Enterprise Value | £259 | £280 | £263 | £284 |
| Revenue | £6 | £13 | £10 | £32 |
| % Growth | -52.8% | 21.3% | -67.7% | – |
| Gross Profit | £2 | £13 | £11 | £27 |
| % Margin | 28.2% | 100% | 104.4% | 83.6% |
| EBITDA | -£9 | £0 | £11 | -£1 |
| % Margin | -157.7% | 0% | 100.5% | -1.9% |
| Net Income | -£8 | £7 | £11 | £28 |
| % Margin | -136.9% | 55.4% | 100.7% | 87.4% |
| EPS Diluted | -0.23 | 0.19 | 0.29 | 0.73 |
| % Growth | -221.1% | -34.5% | -60.3% | – |
| Operating Cash Flow | £31 | -£3 | -£34 | £26 |
| Capital Expenditures | -£31 | £0 | £0 | £0 |
| Free Cash Flow | £0 | -£3 | -£34 | £26 |